Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Patriot/Meth Act

This article was originally published in The Tan Sheet

Executive Summary

Combat Meth Act cosponsor Sen. Dianne Feinstein (D-Calif.) joined other Senate Democrats and several Republicans in voting against cloture for the Patriot Act Dec. 16. Cloture was not reached as the final vote stood at 52-47, eight votes short of the 60 that are needed. The Patriot Act now includes the anti-meth measure that would place drugs containing pseudoephedrine behind the counter, require purchasers to show ID and sign a logbook, and set a purchase limit of 9 g/month. The version of the Patriot Act containing the new provisions passed the House Dec. 14 by a vote of 251-174. In the Senate, debate will continue until the Senate recesses for the holidays. If reauthorization of the Patriot Act does not occur before its expiration Dec. 31, it is unsure whether supporters of the Meth Act will attempt to include the legislation in another measure or pass it as a stand-alone bill, according to Feinstein...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS098946

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel